51 related articles for article (PubMed ID: 29702091)
21. The Targeting of Noncoding RNAs by Quercetin in Cancer Prevention and Therapy.
Wang M; Chen X; Yu F; Zhang L; Zhang Y; Chang W
Oxid Med Cell Longev; 2022; 2022():4330681. PubMed ID: 35656022
[TBL] [Abstract][Full Text] [Related]
22. MALAT1-related signaling pathways in colorectal cancer.
Xu WW; Jin J; Wu XY; Ren QL; Farzaneh M
Cancer Cell Int; 2022 Mar; 22(1):126. PubMed ID: 35305641
[TBL] [Abstract][Full Text] [Related]
23. Divergent regulation of lncRNA expression by ischemia in adult and aging mice.
Kaucsár T; Róka B; Tod P; Do PT; Hegedűs Z; Szénási G; Hamar P
Geroscience; 2022 Feb; 44(1):429-445. PubMed ID: 34697716
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells.
Khalili-Tanha G; Moghbeli M
Cell Mol Biol Lett; 2021 Aug; 26(1):39. PubMed ID: 34425750
[TBL] [Abstract][Full Text] [Related]
25. The effect of targeted regulation of LATS2 by LncRNA BCAR4 on proliferation, migration and apoptosis of HCC cells.
Huang Y; Rao X; Luo Y; Deng Y; Zhong C
Am J Transl Res; 2021; 13(5):4624-4631. PubMed ID: 34150042
[TBL] [Abstract][Full Text] [Related]
26. Significance of Oncotype DX 21-Gene Test and Expression of Long Non-Coding RNA MALAT1 in Early and Estrogen Receptor-Positive Breast Cancer Patients.
Huang Z; Qin Q; Xia L; Lian B; Tan Q; Yu Y; Mo Q
Cancer Manag Res; 2021; 13():587-593. PubMed ID: 33519238
[TBL] [Abstract][Full Text] [Related]
27. Regulatory Networks of LncRNA MALAT-1 in Cancer.
Fu S; Wang Y; Li H; Chen L; Liu Q
Cancer Manag Res; 2020; 12():10181-10198. PubMed ID: 33116873
[TBL] [Abstract][Full Text] [Related]
28. The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma.
Garofoli M; Volpicella M; Guida M; Porcelli L; Azzariti A
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32911687
[TBL] [Abstract][Full Text] [Related]
29. The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response.
Cámara-Quílez M; Barreiro-Alonso A; Vizoso-Vázquez Á; Rodríguez-Belmonte E; Quindós-Varela M; Lamas-Maceiras M; Cerdán ME
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867128
[TBL] [Abstract][Full Text] [Related]
30. MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4.
Zheng RP; Ma DK; Li Z; Zhang HF
Cancer Manag Res; 2020; 12():6165-6175. PubMed ID: 32801865
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling.
Li Q; Jiang B; Qi Y; Zhang H; Ma H
Cancer Biol Ther; 2020 Sep; 21(9):806-814. PubMed ID: 32687454
[TBL] [Abstract][Full Text] [Related]
32. Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma
Xu T; Guo P; Pi C; He Y; Yang H; Hou Y; Feng X; Jiang Q; Wei Y; Zhao L
J Cancer; 2020; 11(13):3955-3964. PubMed ID: 32328199
[TBL] [Abstract][Full Text] [Related]
33. MALAT1 regulates miR-34a expression in melanoma cells.
Li F; Li X; Qiao L; Liu W; Xu C; Wang X
Cell Death Dis; 2019 May; 10(6):389. PubMed ID: 31101802
[TBL] [Abstract][Full Text] [Related]
34. New Insights into Long Non-Coding RNA
Sun Y; Ma L
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781877
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
[TBL] [Abstract][Full Text] [Related]
36. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
37. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
[TBL] [Abstract][Full Text] [Related]
38. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
39. Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches.
Gupta R; Kadhim MM; Turki Jalil A; Obayes AM; Aminov Z; Alsaikhan F; Ramírez-Coronel AA; Ramaiah P; Tayyib NA; Luo X
Environ Res; 2023 Jul; 228():115767. PubMed ID: 36966991
[TBL] [Abstract][Full Text] [Related]
40. Comment on: an orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agent.
Li X; Liang R
Invest New Drugs; 2021 Apr; 39(2):537. PubMed ID: 33123815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
